Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1271606

registered interest
date	16/12/2020
answering body	Department for Digital, Culture, Media and Sport
answering dept id	10
answering dept short name	Digital, Culture, Media and Sport
answering dept sort name	Digital, Culture, Media and Sport
hansard heading	Internet: Safety
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Digital, Culture, Media and Sport, with reference to the Government response to the Digital, Culture, Media & Sport Select Committee Report on Immersive and Addictive Technologies, published on 8 June 2020, what plans he has to introduce legislative proposals to require companies to use a proportionate range of tools including age assurance, and age verification technologies to prevent children from accessing age-inappropriate content.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	130737
answer	answer is ministerial correction date of answer 11/01/2021 answer text <p>Protecting children is at the heart of our online harms agenda, and wider government priorities. We have now published our Full Government Response to the Online Harms White Paper, which sets out how a proposed legal duty of care on online companies will work in practice and gives them new responsibilities towards their users. We are working at pace to have legislation ready next year.</p><p>Services which are likely to be accessed by children will be required to provide additional protections for children using them. Companies will be required to assess the risk their service poses for children, put in place proportionate measures to protect children, and monitor these for effectiveness. Under our proposals, we expect companies to use age assurance or age verification technologies to prevent children from accessing services which pose the highest risk of harm to children, such as online pornography. Companies will also need to provide age-appropriate protections from harmful content and activity for children using their service.</p><p>We would encourage companies to take steps ahead of the legislation to protect children from harmful and age inappropriate content online. We are working closely with stakeholders across industry to establish the right conditions for the market to deliver age assurance and age verification technical solutions ahead of the legislative requirements coming into force.</p><p> </p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 11/01/2021 11:07:55 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4131 label Biography information for Jim Shannon

1271607

registered interest
date	16/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Obesity: Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what data his Department holds on regional variation in the provision of weight loss surgery for obese people; and if he will instruct Clinical Commissioning Groups to work with independent providers to improve provision of that service during the covid-19 outbreak.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	130738
answer	answer is ministerial correction date of answer 11/01/2021 answer text <p>The Department does not hold data on the provision of weight loss surgery. Clinical commissioning groups (CCGs) are responsible for commissioning complex obesity services for adults, which include all bariatric surgical procedures and the associated care.</p><p> </p><p>There has been no central assessment or discussions with CCGs on the provision of bariatric services for obese people in response to the COVID-19 outbreak.</p><p> </p><p>Through ‘Tackling obesity: empowering adults and children to live healthier lives’ we are delivering a range of measures on weight management, including expanding weight management services to help more people get the support they need and making conversations about weight in primary care the norm. Further details about these measures will be available shortly.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 130739 130740 question first answered 11/01/2021 21:53:07 answering member 4380 label Biography information for Jo Churchill
tabling member	4131 label Biography information for Jim Shannon

1271608

registered interest
date	16/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Obesity: Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of instructing Clinical Commissioning Groups to improve provision of bariatric services for obese people in response to the covid-19 outbreak.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	130739
answer	answer is ministerial correction date of answer 11/01/2021 answer text <p>The Department does not hold data on the provision of weight loss surgery. Clinical commissioning groups (CCGs) are responsible for commissioning complex obesity services for adults, which include all bariatric surgical procedures and the associated care.</p><p> </p><p>There has been no central assessment or discussions with CCGs on the provision of bariatric services for obese people in response to the COVID-19 outbreak.</p><p> </p><p>Through ‘Tackling obesity: empowering adults and children to live healthier lives’ we are delivering a range of measures on weight management, including expanding weight management services to help more people get the support they need and making conversations about weight in primary care the norm. Further details about these measures will be available shortly.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 130738 130740 question first answered 11/01/2021 21:53:07 answering member 4380 label Biography information for Jo Churchill
tabling member	4131 label Biography information for Jim Shannon

1271609

registered interest
date	16/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Obesity: Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions his Department has had with Clinical Commissioning Groups on the accessibility of bariatric surgery during the covid-19 outbreak.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	130740
answer	answer is ministerial correction date of answer 11/01/2021 answer text <p>The Department does not hold data on the provision of weight loss surgery. Clinical commissioning groups (CCGs) are responsible for commissioning complex obesity services for adults, which include all bariatric surgical procedures and the associated care.</p><p> </p><p>There has been no central assessment or discussions with CCGs on the provision of bariatric services for obese people in response to the COVID-19 outbreak.</p><p> </p><p>Through ‘Tackling obesity: empowering adults and children to live healthier lives’ we are delivering a range of measures on weight management, including expanding weight management services to help more people get the support they need and making conversations about weight in primary care the norm. Further details about these measures will be available shortly.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 130738 130739 question first answered 11/01/2021 21:53:07 answering member 4380 label Biography information for Jo Churchill
tabling member	4131 label Biography information for Jim Shannon

1271610

registered interest
date	16/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Embryos and Foetal Tissue: Overseas Trade
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the traceability of human embryos, gametes and aborted fetal tissue imported into or exported from the UK.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	130741
answer	answer is ministerial correction date of answer 11/01/2021 answer text <p>The Human Tissue Act 2004 makes no distinction between pregnancy remains and other tissue from a living person. Tissue for use in human application or for research is regulated by the Human Tissue Authority (HTA). HTA-licensed establishments maintain inventories of the material they hold and, by meeting expected standards on coding and records, are able to demonstrate full traceability for the human material for which they are responsible, from receipt to final disposal/disposition. Since 2018, the HTA has collected information from its licenced establishments on the import of fetal material intended for use in human application.</p><p> </p><p>All imported human embryos and gametes and all those transported across UK borders are registered with the Human Fertilisation and Embryology Authority (HFEA), as required by the Human Fertilisation and Embryology Act 1990, as amended, and recently updated under the Human Fertilisation and Embryology (Amendment) (EU Exit) Regulations 2020. Further requirements, including traceability requirements, can be found in the General Directions issued by the HFEA and in the HFEA Code of Practice.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 130742 130743 question first answered 11/01/2021 12:51:43 answering member 4527 label Biography information for Helen Whately
tabling member	4131 label Biography information for Jim Shannon

1271611

registered interest
date	16/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Foetal Tissue: Overseas Trade
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department takes to monitor the import into or export from the UK of human fetal tissue.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	130742
answer	answer is ministerial correction date of answer 11/01/2021 answer text <p>The Human Tissue Act 2004 makes no distinction between pregnancy remains and other tissue from a living person. Tissue for use in human application or for research is regulated by the Human Tissue Authority (HTA). HTA-licensed establishments maintain inventories of the material they hold and, by meeting expected standards on coding and records, are able to demonstrate full traceability for the human material for which they are responsible, from receipt to final disposal/disposition. Since 2018, the HTA has collected information from its licenced establishments on the import of fetal material intended for use in human application.</p><p> </p><p>All imported human embryos and gametes and all those transported across UK borders are registered with the Human Fertilisation and Embryology Authority (HFEA), as required by the Human Fertilisation and Embryology Act 1990, as amended, and recently updated under the Human Fertilisation and Embryology (Amendment) (EU Exit) Regulations 2020. Further requirements, including traceability requirements, can be found in the General Directions issued by the HFEA and in the HFEA Code of Practice.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 130741 130743 question first answered 11/01/2021 12:51:43 answering member 4527 label Biography information for Helen Whately
tabling member	4131 label Biography information for Jim Shannon

1271612

registered interest
date	16/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Foetal Tissue: Imports and Exports
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what information his Department holds on the transportation of human (a) gametes, (b) embryos and (c) tissue from aborted fetuses across UK borders in the last five years.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	130743
answer	answer is ministerial correction date of answer 11/01/2021 answer text <p>The Human Tissue Act 2004 makes no distinction between pregnancy remains and other tissue from a living person. Tissue for use in human application or for research is regulated by the Human Tissue Authority (HTA). HTA-licensed establishments maintain inventories of the material they hold and, by meeting expected standards on coding and records, are able to demonstrate full traceability for the human material for which they are responsible, from receipt to final disposal/disposition. Since 2018, the HTA has collected information from its licenced establishments on the import of fetal material intended for use in human application.</p><p> </p><p>All imported human embryos and gametes and all those transported across UK borders are registered with the Human Fertilisation and Embryology Authority (HFEA), as required by the Human Fertilisation and Embryology Act 1990, as amended, and recently updated under the Human Fertilisation and Embryology (Amendment) (EU Exit) Regulations 2020. Further requirements, including traceability requirements, can be found in the General Directions issued by the HFEA and in the HFEA Code of Practice.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 130741 130742 question first answered 11/01/2021 12:51:43 answering member 4527 label Biography information for Helen Whately
tabling member	4131 label Biography information for Jim Shannon

1271613

registered interest
date	16/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Foetal Tissue
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the Quality and Safety of Organs Intended for Transplantation (Amendment) (EU Exit) Regulations 2020 applies to aborted fetal tissue.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	130744
answer	answer is ministerial correction date of answer 11/01/2021 answer text <p>The Quality and Safety of Organs Intended for Transplantation (Amendment) (EU Exit) Regulations 2020 cover the quality and safety of activities relating to organs intended for donation and transplantation and do not cover pregnancy remains.</p><p> </p><p>The Human Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2020 amend the Human Tissue (Quality and Safety for Human Application) Regulations 2007 and regulate the quality and safety of activities concerning human tissues and cells, intended for use in human application. These regulations apply to pregnancy remains to the extent they are used for human application.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 11/01/2021 14:25:31 answering member 4527 label Biography information for Helen Whately
tabling member	4131 label Biography information for Jim Shannon